The VICC.ORG Directory of Cancers: Treatments, Services & Resources
Gastrointestinal Cancers
The Gastrointestinal (GI) Oncology Program focuses on malignancies of the esophagus, stomach, small intestine, colon, rectum, anus, liver, gallbladder, pancreas and bile ducts.
Types of Gastrointestinal Cancer
Treatment at Vanderbilt
Gastrointestinal Cancer News
Clinical Trials for Gastrointestinal Cancers
23 Open Trials
| Trial Type & Disease | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic Liver | VICCGI1183 04/04/2012 | A Randomized, Placebo-controlled, Double-blind, Multicenter Phase II Trial of Intravenous GC33 at 1600 mg Q2W in Previously Treated Patients with Unresectable Advanced or Metastatic Hepatocellular Carcinoma (HCC) |
| Therapeutic Pancreatic | VICCGI1140 11/18/2011 | A Phase II/III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer |
| Therapeutic Breast; Esophageal; Gastric/Gastroesophageal; Head/Neck; Non Small Cell; Small Cell | VICCGI1068 06/08/2011 | A Phase I Dose Escalation Study of MLN8237, an Aurora A Kinase Inhibitor, in Adult Patients with Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck, or Gastroesophageal Malignancies |
| Therapeutic Colon; Rectal | VICCGI1058 06/03/2011 | An Investigator Initiated, Phase II Study of Linifanib in Patients with Advanced, Refractory Colorectal Cancer Expressing Mutated kRas |
| Therapeutic Liver | CTSUGI80702-M 05/05/2011 | A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer |
| Therapeutic Liver | CTSUGIC80802-M 12/07/2010 | Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC) |
| Therapeutic Pancreatic | VICCGI1016 12/07/2010 | Phase II Study of STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer |
| Therapeutic Colon; Rectal | VICCGI09106 10/04/2010 | Phase I Study of Cetuximab with RO4929097 in Metastatic Colorectal Cancer |
| Therapeutic Colon; Rectal | VICCGI0999 09/10/2010 | An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) in Combination with IMC-1121B or IMC-18F1 or without Investigational Therapy as Second-line Therapy in Patients with Metastatic Colorectal Cancer Following Disease Progression on First-line Irinotecan-based Therapy |
| Therapeutic GIST | VICCPHI0958 02/05/2010 | A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX3397 in Patients with Advanced, Incurable, Solid Tumors in which the Target Kinases Are Linked to Disease Pathophysiology |
| Therapeutic Pancreatic | VICCGI0934 10/05/2009 | Phase I Trial of Chemoradiation with Capecitabine and Vorinostat in Pancreatic Cancer. |
| Therapeutic Rectal | VICCGI0870 07/17/2009 | Phase II study of Cetuximab, 5FU and Radiation as Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer |
| Therapeutic Pancreatic | ACOSOGGIZ5041 04/14/2009 | A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma. |
| Therapeutic Neuroendocrine | ECOGGIS0518 10/02/2008 | Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon vs. Depot Octreotide Plus Bevacizumab in Advanced Poor Prognosis Carcinoid Patients |
| Ancillary Rectal | VICCGI0993 03/23/2010 | Molecular Determinants Affecting FLT PET in Rectal Cancer |
| Correlative Colon | VICCGI0859 08/22/2008 | Proteomic Analysis of FFPE Tissues from Adenomas of the Colon |
| Correlative Pancreatic | VICCGI0717 05/07/2007 | Developing Biomarkers in Pancreatic Cancer |
| Epidemiology, Observation, Outcomes Breast; Colon; Lung; Rectal | VICCREACH1113 05/10/2011 | Formative Research Needs to Address the Differing Needs of Cancer Survivors (Pilot #1 of the MMC and VICC Partnering for Survivorship Project) |
| Epidemiology, Observation, Outcomes Breast - Female; Colon; Lung; Prostate; Rectum | VICCREACH1086P20PILOT2-M 02/23/2011 | Assessing the needs for Cancer Survivors |
| Epidemiology, Observation, Outcomes Colon; Rectal | VICCGI0721 01/09/2007 | Vanderbilt Hereditary Colorectal Cancer Registry |
| Epidemiology, Observation, Outcomes Liver; Neuroendocrine | VICCGI0372 10/01/2003 | Outcomes Following Image-Guided Therapy for Hepatic Malignancies. |
| Screen, Detect, Diagnose Colon; Rectal | VICCGI1156 02/03/2012 | Research use of human biospecimens from colorectal cancer patients and clinical testing for the assignment of therapy |
| Screen, Detect, Diagnose | VICCGI0283 06/01/2002 | Novel Gastrointestinal Cancer Markers in Tissue and Biofluids |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
